Tinzaparin clinical trials
Also written Innohep.
How each study uses Tinzaparin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Get an email when these change. Save the Tinzaparin studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.
See an example email
Example · made-up studies
Breast cancer · Recruiting: 2 came in, 3 changed
What changed in your alerts, Oct 31 – Nov 6:
A study of drug A after surgery for early breast cancer
Came in · now Recruiting
Drug B with hormone therapy in advanced breast cancer
Changed
· Sites: 4 added, including Seoul and Busan
· Enrollment: 300 → 450 participants
Exercise during chemotherapy
Now Active, not recruiting
One email a week for all your alerts. Stop any time.
Approvals
The first approval found in each region, with its record
- United States
- 14 Jul 2000 · INNOHEP · NDA 020484 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
37 studies that test it; most in 2005 (5)
| Year | Studies |
|---|---|
| 1993 | 1 |
| 1994 | 1 |
| 1997 | 1 |
| 2002 | 2 |
| 2003 | 2 |
| 2004 | 2 |
| 2005 | 5 |
| 2007 | 1 |
| 2009 | 1 |
| 2010 | 1 |
| 2011 | 2 |
| 2013 | 2 |
| 2015 | 1 |
| 2016 | 1 |
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 3 |
| 2022 | 4 |
| 2023 | 2 |
| 2024 | 2 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 2 · Other 35
Ottawa Hospital Research Institute (4) · University of Calgary (3) · LEO Pharma (2) · Assistance Publique - Hôpitaux de Paris (2) · Centre Hospitalier Universitaire, Amiens (1) · University of Melbourne (1) · Alexandra Hospital, Athens, Greece (1) · Galician Research Group on Digestive Tumors (1)
Often tested with
Tested in the same studies.
Dalteparin (7) · Enoxaparin (6) · Rivaroxaban (2) · Apixaban (2) · Nafamostat (1) · Nirmatrelvir (1) · Ritonavir (1) · Remdesivir (1)
Related medicines
As reviewed, each with the page that says it.
Coming up
From the study records. Dates are the sponsors’ own estimates and often move.
Reaching primary completion within a year · 2
Studies that test Tinzaparin.
- Dec 2026STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated ThrombosisPhase 4 · Tzu-Fei Wang
- Jun 2027THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)Phase 4 · Imperial College London
Studies
Open first, then newest update. How each study uses Tinzaparin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 37
- Thromboprophylaxis in Lower Limb ImmobilisationRecruitingPhase 3Queen Mary University of LondonNCT06370273Written as Tinzaparin Injectable SolutionHow we know
- THRomboprophylaxis in Individuals Undergoing Superficial endoVEnous Treatment (THRIVE)RecruitingPhase 4Imperial College LondonNCT05735639Written as Tinzaparin SodiumHow we know
- The OAT Trail: The Obesity Anti-Coagulation Thromboprophylaxis Trial.Not yet recruitingNot applicableUniversity College DublinNCT07559643Written as Tinzaparin (Leo)How we know
- Tinzaparin And Biomarkers After Neoadjuvant Treatment of Ovarian CancerRecruitingPhase 2University Hospital, LinkoepingNCT05284552Written as Tinzaparin Injectable SolutionHow we know
- STrategies for Anticoagulation in Patients With thRombocytopenia and Cancer-associated ThrombosisRecruitingPhase 4Tzu-Fei WangNCT05255003Written as TinzaparinHow we know
- Pre- Vs. Postoperative Thromboprophylaxis in Pancreatic SurgeryRecruitingPhase 4Helsinki University Central HospitalNCT05245877Written as enoxaparin/tinzaparin/dalteparinHow we know
- LDA and LMWH vs LDA Alone in High-risk Patients for Preeclampsia PreventionCompletedPhase 4Alexandra Hospital, Athens, GreeceNCT07361679Written as TinzaparinHow we know
- TINzaparin Prophylaxis in Patients With Metastatic Colorectal CancerCompletedPhase 3Galician Research Group on Digestive TumorsNCT05625932Written as TinzaparinHow we know
- Effect of Tinzaparin on Inflammatory Biomarkers During the Acute Phase of Deep Vein ThrombosisActive, not recruitingNot applicableCentre Hospitalier Universitaire, AmiensNCT04741464Written as TinzaparinHow we know
- Innohep® in Elderly Patients With Impaired Renal Function Treated for Acute Deep Vein ThrombosisCompletedPhase 4LEO PharmaNCT00277394Written as innohep®How we know
- Long-Term Innohep® Treatment Versus a Vitamin K Antagonist (Warfarin) for the Treatment of Venous Thromboembolism (VTE) in CancerCompletedPhase 3LEO PharmaNCT01130025Written as Innohep®How we know
- Australasian COVID-19 Trial (ASCOT) ADAptive Platform TrialActive, not recruitingPhase 3University of MelbourneNCT04483960Written as (Arm Closed) TinzaparinHow we know
- Tinzaparin Lead-In to Prevent the Post-Thrombotic SyndromeTerminatedPhase 4Sunnybrook Health Sciences CentreNCT04794569Written as tinzaparinHow we know
- Therapeutic Anticoagulation Strategy for Acute Chest SyndromeCompletedPhase 3Assistance Publique - Hôpitaux de ParisNCT02580773Written as Prophylactic anticoagulation ( INNOHEP®)How we know
- Prophylaxis of Venous Thromboembolism in Advanced Lung Cancer (PROVE)TerminatedPhase 3Assistance Publique - Hôpitaux de ParisNCT03090880Written as Tinzaparin SodiumHow we know
- Standard vs High Prophylactic Doses or Anticoagulation in Patients With High Risk of Thrombosis Admitted With COVID-19 Pneumonia (PROTHROMCOVID)CompletedNot applicableHospital Universitario Infanta LeonorNCT04730856Written as TinzaparinHow we know
- Comparison of Low and Intermediate Dose Low-molecular-weight Heparin to Prevent Recurrent Venous Thromboembolism in PregnancyCompletedPhase 4Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)NCT01828697Written as Fixed low dose tinzaparinHow we know
- The Impact of Thromboprophylaxis on Progression Free Survival of Patients With Advanced Pancreatic CancerStatus unknownPhase 3Michalis KaramouzisNCT05178628Written as InnohepHow we know
- Extended Peri-operative Tinzaparin to Improve Disease-free Survival in Patients With Resectable Colorectal CancerCompletedPhase 3Ottawa Hospital Research InstituteNCT01455831Written as TinzaparinHow we know
- The STOP CLOT Pilot Study: Study of Low Molecular Weight Heparin in High Risk Cesarean SectionCompletedPhase 2/3Ottawa Hospital Research InstituteNCT00225108Written as TinzaparinHow we know
See all 37 studies that test Tinzaparin →
Given beside what is tested · 1 — Tinzaparin is usual care or a partner of the new treatment
Codes
What other systems call Tinzaparin · ClinicalTrials.gg INT006820
- MeSH (NLM) D000078222TinzaparinConfirmed ClinicalTrials.gov, NLM, Wikidata
- UNII (FDA) 7UQ7X4Y489TINZAPARINConfirmed FDA, NLM, Wikidata
- RxNorm 69646Confirmed FDA, Wikidata
- Wikidata Q20817252tinzaparinConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C87297TinzaparinOne source FDA
- DrugBank DB06822One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000078222 | Tinzaparin | Confirmed ClinicalTrials.gov, NLM, Wikidata |
| UNII (FDA) | 7UQ7X4Y489 | TINZAPARIN | Confirmed FDA, NLM, Wikidata |
| RxNorm | 69646 | — | Confirmed FDA, Wikidata |
| Wikidata | Q20817252 | tinzaparin | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C87297 | Tinzaparin | One source FDA |
| DrugBank | DB06822 | — | One source Wikidata |
Also registered as tinzaparin sodium (UNII 3S182ET3UA · RxNorm 104466).
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.